Five reference materials that appear throughout preclinical literature on tissue injury, fibroblast behavior and inflammation models, each with a lot-specific certificate of analysis.
These compounds share a research theme rather than a mechanism. BPC-157 is a 15-residue fragment of a gastric protein studied mostly in rodent tendon, muscle and gastrointestinal models. Thymosin β4 and the shorter TB-500 name are associated with actin binding and cell-migration research. GHK-Cu is a copper-binding tripeptide found naturally in plasma and widely studied in fibroblast and extracellular-matrix work. KPV is the C-terminal tripeptide of alpha-MSH, used in inflammation and intestinal-model research.
Nearly all of this literature is preclinical. None of these compounds is an approved drug, and the materials below are supplied strictly for in-vitro laboratory research. Each product page summarizes the published research with PubMed references and lists the identity data we can verify.
| Material | Class | Where it appears in research | Current lot purity |
|---|---|---|---|
| BPC-157 10mg | Synthetic pentadecapeptide | Rodent tendon, muscle and GI models; fibroblast migration | 99.69% |
| BPC-157 / TB-500 20mg | Two-peptide blend | Comparing BPC-157 and thymosin β4-related research in one lot | 99.09% |
| GHK-Cu 100mg | Copper tripeptide complex | Fibroblast, collagen and extracellular-matrix studies | 99.88% |
| KPV 10mg | Alpha-MSH C-terminal tripeptide | Inflammation and intestinal epithelium models | 99.94% |
| KLOW 80mg | Four-component blend (GHK-Cu, BPC-157, TB-500, KPV) | Multi-compound in-vitro screening from one documented lot | 99.69% |
Purity is the HPLC result for the lot currently shipping. See every published certificate in our lab results dataset.
Single compounds (BPC-157, GHK-Cu, KPV) suit experiments that need one variable. The blends are convenience formats for labs that want several of these peptides from a single documented lot; published studies examined each peptide separately, so blend results should be interpreted with that in mind.
Each lot is tested by an independent laboratory before release, with HPLC purity and an identity result on the certificate of analysis. The lot number in your order confirmation matches a specific certificate, which you can look up on the lot verification page. Lots below 99% purity are not released.
It describes the research models these compounds appear in, such as rodent tendon injury, wound and fibroblast-culture studies. It is a literature category, not a claim about any effect in people. All materials are for in-vitro laboratory research only.
Not exactly. Thymosin β4 is a 43-residue protein. The name TB-500 is most often used for a short synthetic fragment of it, though some sources use it loosely for the full protein. Most published clinical-stage research used full-length thymosin β4.
An independent laboratory reports HPLC purity and an identity result for every lot. The lot number on your order confirmation links to its certificate on our lot-verification page, and every published result is listed in our lab results dataset.
BPC-157 vs TB-500: a research comparisonGHK-Cu research backgroundKPV research background
Mitochondrial & metabolic research compoundsGrowth-hormone axis research peptidesNeuropeptide research compounds
Browse all research materials →